Geode Capital Management LLC Boosts Stock Holdings in Stryker Corporation $SYK

Geode Capital Management LLC grew its position in shares of Stryker Corporation (NYSE:SYK) by 0.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,535,572 shares of the medical technology company’s stock after acquiring an additional 69,851 shares during the quarter. Geode Capital Management LLC owned 1.97% of Stryker worth $2,636,238,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently bought and sold shares of the company. United Financial Planning Group LLC purchased a new position in Stryker during the 3rd quarter worth $27,000. Strive Asset Management LLC purchased a new position in shares of Stryker in the 3rd quarter worth about $30,000. CGC Financial Services LLC purchased a new position in shares of Stryker in the 4th quarter worth about $29,000. ANTIPODES PARTNERS Ltd purchased a new position in shares of Stryker in the 3rd quarter worth about $34,000. Finally, Ares Financial Consulting LLC purchased a new position in shares of Stryker in the 4th quarter worth about $40,000. 77.09% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Stryker news, VP M Kathryn Fink sold 3,500 shares of the company’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $283.45, for a total transaction of $992,075.00. Following the sale, the vice president directly owned 177 shares of the company’s stock, valued at $50,170.65. This represents a 95.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 4.60% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Sanford C. Bernstein set a $410.00 price target on shares of Stryker in a report on Friday, May 1st. Leerink Partners assumed coverage on shares of Stryker in a report on Monday, April 13th. They issued an “outperform” rating and a $410.00 price target on the stock. William Blair reissued an “outperform” rating on shares of Stryker in a report on Thursday, March 5th. Truist Financial reissued a “hold” rating and issued a $330.00 price target (down from $380.00) on shares of Stryker in a report on Monday, May 4th. Finally, JPMorgan Chase & Co. cut their price target on shares of Stryker from $445.00 to $400.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Sixteen analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $395.48.

Stryker Price Performance

NYSE SYK opened at $306.16 on Thursday. The company has a market cap of $117.37 billion, a PE ratio of 35.44, a price-to-earnings-growth ratio of 1.97 and a beta of 0.80. Stryker Corporation has a 52 week low of $281.00 and a 52 week high of $404.87. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62. The firm’s 50-day simple moving average is $323.45 and its two-hundred day simple moving average is $348.79.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 EPS for the quarter, missing the consensus estimate of $2.98 by ($0.38). The business had revenue of $6.02 billion for the quarter, compared to analysts’ expectations of $6.34 billion. Stryker had a net margin of 13.20% and a return on equity of 23.42%. Stryker’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same period last year, the company earned $2.84 earnings per share. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Research analysts predict that Stryker Corporation will post 14.98 earnings per share for the current year.

Stryker Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be issued a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.52 annualized dividend and a yield of 1.1%. Stryker’s dividend payout ratio is 40.74%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.